| PERIOD ENDING | 31-Dec-08 | | Total Revenue |
-
| | Cost of Revenue |
-
| | | Gross Profit |
-
| | | Operating Expenses | | Research Development |
-
| | Selling General and Administrative | 393 | | Non Recurring |
-
| | Others |
-
| | | | Total Operating Expenses |
-
| | | | Operating Income or Loss | (393) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 1,440 | | Earnings Before Interest And Taxes | 1,047 | | Interest Expense |
-
| | Income Before Tax | 1,047 | | Income Tax Expense |
-
| | Minority Interest |
-
| | | | Net Income From Continuing Ops | 1,047 | | | Non-recurring Events | | Discontinued Operations |
-
| | Extraordinary Items |
-
| | Effect Of Accounting Changes |
-
| | Other Items |
-
| | | | Net Income | 1,047 | | Preferred Stock And Other Adjustments |
-
| | | Net Income Applicable To Common Shares | $1,047 |
|
0.63% Nasdaq 
0.03%
Income Statement
